The Saudi Thoracic Society Guidelines for Diagnosis and Management of Noncystic Fibrosis Bronchiectasis

Overview

Journal Ann Thorac Med

Specialty Pulmonary Medicine

Date 2017 Aug 16

PMID 28808486

Citations 17

Authors

Hamdan Al-Jahdali

Abdullah Alshimemeri

Abdullah Mobeireek

Amr S Albanna

Nehad N Al Shirawi

Siraj Wali

Khaled Alkattan

Abdulrahman A Alrajhi

Khalid Mobaireek

Hassan S Alorainy

Mohamed S Al-Hajjaj

Anne B Chang

Stefano Aliberti

Affiliations

Soon will be listed here.

Abstract

This is the first guideline developed by the Saudi Thoracic Society for the diagnosis and management of noncystic fibrosis bronchiectasis. Local experts including pulmonologists, infectious disease specialists, thoracic surgeons, respiratory therapists, and others from adult and pediatric departments provided the best practice evidence recommendations based on the available international and local literature. The main objective of this guideline is to utilize the current published evidence to develop recommendations about management of bronchiectasis suitable to our local health-care system and available resources. We aim to provide clinicians with tools to standardize the diagnosis and management of bronchiectasis. This guideline targets primary care physicians, family medicine practitioners, practicing internists and respiratory physicians, and all other health-care providers involved in the care of the patients with bronchiectasis.

Citing Articles

The Saudi Thoracic Society Evidence-based guidelines for the diagnosis and management of chronic obstructive pulmonary disease.

Al-Jahdali H, Al-Lehebi R, Lababidi H, Alhejaili F, Habis Y, Alsowayan W Ann Thorac Med. 2025; 20(1):1-35.

PMID: 39926399 PMC: 11804957. DOI: 10.4103/atm.atm_155_24.

Development of evidence-based standards for inpatient physiotherapy services: a systematic review and content analysis of clinical practice guidelines.

Plater J, Baxter G, Wood L, Mueller J, Fisher T BMJ Open. 2024; 14(12):e088692.

PMID: 39719293 PMC: 11667250. DOI: 10.1136/bmjopen-2024-088692.

mucinous phenotypes and operon mutant characteristics obtained from inpatients with bronchiectasis and their correlation with acute aggravation.

Tan Y, Dai Z Front Cell Infect Microbiol. 2024; 14:1402348.

PMID: 39135639 PMC: 11317387. DOI: 10.3389/fcimb.2024.1402348.

Bronchiectasis management in adults: state of the art and future directions.

Choi H, McShane P, Aliberti S, Chalmers J Eur Respir J. 2024; 63(6).

PMID: 38782469 PMC: 11211698. DOI: 10.1183/13993003.00518-2024.

Global survey of physician testing practices for nontuberculous mycobacteria.

Loebinger M, van der Laan R, Obradovic M, van Ingen J ERJ Open Res. 2023; 9(3).

PMID: 37143838 PMC: 10152245. DOI: 10.1183/23120541.00737-2022.

References

Pasteur M, Bilton D, Hill A . British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010; 65(7):577. DOI: 10.1136/thx.2010.142778. View

Etienne T, Spiliopoulos A, MEGEVAND R . [Bronchiectasis: indication and timing for surgery]. Ann Chir. 1993; 47(8):729-35. View

Chang A, Bell S, Torzillo P, King P, Maguire G, Byrnes C . Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Med J Aust. 2015; 202(3):130. DOI: 10.5694/mjac14.00287. View

Haidopoulou K, Calder A, Jones A, Jaffe A, Sonnappa S . Bronchiectasis secondary to primary immunodeficiency in children: longitudinal changes in structure and function. Pediatr Pulmonol. 2009; 44(7):669-75. DOI: 10.1002/ppul.21036. View

Yang J, Fan L, Lu H, Miao X, Mao B, Xu J . Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis. Clin Respir J. 2015; 10(6):731-739. DOI: 10.1111/crj.12278. View

Amorim A, Bento J, Vaz A, Gomes I, De Gracia J, Hespanhol V . Bronchiectasis: a retrospective study of clinical and aetiological investigation in a general respiratory department. Rev Port Pneumol (2006). 2015; 21(1):5-10. DOI: 10.1016/j.rppnen.2014.06.009. View

Lee A, Hill C, McDonald C, Holland A . Pulmonary Rehabilitation in Individuals With Non-Cystic Fibrosis Bronchiectasis: A Systematic Review. Arch Phys Med Rehabil. 2016; 98(4):774-782.e1. DOI: 10.1016/j.apmr.2016.05.017. View

Henrichfreise B, Wiegand I, Luhmer-Becker I, Wiedemann B . Development of resistance in wild-type and hypermutable Pseudomonas aeruginosa strains exposed to clinical pharmacokinetic profiles of meropenem and ceftazidime simulated in vitro. Antimicrob Agents Chemother. 2007; 51(10):3642-9. PMC: 2043282. DOI: 10.1128/AAC.00160-07. View

Kapur N, Grimwood K, Masters I, Morris P, Chang A . Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis. Pediatr Pulmonol. 2011; 47(3):300-7. DOI: 10.1002/ppul.21550. View

10.

Li A, Sonnappa S, Lex C, Wong E, Zacharasiewicz A, Bush A . Non-CF bronchiectasis: does knowing the aetiology lead to changes in management?. Eur Respir J. 2005; 26(1):8-14. DOI: 10.1183/09031936.05.00127704. View

11.

Currie D, Cooke J, Morgan A, KERR I, Delany D, STRICKLAND B . Interpretation of bronchograms and chest radiographs in patients with chronic sputum production. Thorax. 1987; 42(4):278-84. PMC: 460705. DOI: 10.1136/thx.42.4.278. View

12.

Martinez-Garcia M, Perpina-Tordera M, Roman-Sanchez P, Soler-Cataluna J . Inhaled steroids improve quality of life in patients with steady-state bronchiectasis. Respir Med. 2006; 100(9):1623-32. DOI: 10.1016/j.rmed.2005.12.002. View

13.

Taskar V, Sharma R, Goswami R, John P, Mahashur A . Effect of bromhexeine on sputum amoxycillin levels in lower respiratory infections. Respir Med. 1992; 86(2):157-60. DOI: 10.1016/s0954-6111(06)80233-7. View

14.

Alhamad E, Alanezi M, Idrees M, Chaudhry M, Alshahrani A, Isnani A . Clinical characteristics and computed tomography findings in Arab patients diagnosed with pulmonary sarcoidosis. Ann Saudi Med. 2009; 29(6):454-9. PMC: 2881433. DOI: 10.4103/0256-4947.57168. View

15.

Goeminne P, Scheers H, Decraene A, Seys S, Dupont L . Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients. Respir Res. 2012; 13:21. PMC: 3379934. DOI: 10.1186/1465-9921-13-21. View

16.

Grimwood K, Bell S, Chang A . Antimicrobial treatment of non-cystic fibrosis bronchiectasis. Expert Rev Anti Infect Ther. 2014; 12(10):1277-96. DOI: 10.1586/14787210.2014.952282. View

17.

Gomez Carrera L, Bonilla Hernan G . Pulmonary manifestations of collagen diseases. Arch Bronconeumol. 2013; 49(6):249-60. DOI: 10.1016/j.arbres.2012.11.005. View

18.

Angrill J, Agusti C, De Celis R, Rano A, Gonzalez J, Sole T . Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax. 2002; 57(1):15-9. PMC: 1746176. DOI: 10.1136/thorax.57.1.15. View

19.

Pizzutto S, Upham J, Yerkovich S, Chang A . Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis. Cochrane Database Syst Rev. 2010; (4):CD007525. DOI: 10.1002/14651858.CD007525.pub2. View

20.

Brower K, Del Vecchio M, Aronoff S . The etiologies of non-CF bronchiectasis in childhood: a systematic review of 989 subjects. BMC Pediatr. 2014; 14:4. PMC: 4275950. DOI: 10.1186/s12887-014-0299-y. View